Cimicoxib
-
Catalog numberB1984-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name4-[4-Chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]benzenesulfonamide; UR-8880; UR8880; UR8880; Cimicoxib; trade name: Cimalgex
-
DescriptionCimicoxib is an imidazole derivative and a non-steroidal anti-inflammatory drug (NSAID) that acts as a potent and specific cyclooxygenase-2 (COX-2) inhibitor. Used in veterinary medicine to treat dogs for pain and inflammation associated with osteoarthritis and for the management of pain and inflammation associated with surgery.
-
CAS Number265114-23-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₆H₁₃ClFN₃O₃S
-
Molecular Weight381.81
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA non-steroidal anti-inflammatory drug (NSAID) and a potent cyclooxygenase-2 (COX-2) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID213053
-
SMILESCOC1=C(C=C(C=C1)C2=C(N=CN2C3=CC=C(C=C3)S(=O)(=O)N)Cl)F
-
InChiInChI=1S/C16H13ClFN3O3S/c1-24-14-7-2-10(8-13(14)18)15-16(17)20-9-21(15)11-3-5-12(6-4-11)25(19,22)23/h2-9H,1H3,(H2,19,22,23)
-
InChi KeyKYXDNECMRLFQMZ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCimicoxib
-
Alternative nameCimicoxib
-